Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001103780-15-000071

CEO bought 5,000 shares at $0.20 ($975)

From the SEC's structured data for this filing

Trades in this filing

BUNKA CHRISTOPHER · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2015-12-10 Purchase : show line 1 in the form +5,000 $0.20 $975 6,249,376 D
Open-market purchases · 5,000 sh · avg $0.20 · $975
Loading xslF345X03/primary_doc.xml…